Publicacions en col·laboració amb investigadors/es de University of Liverpool (8)

2022

  1. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

    Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 2, pp. 475-485

  2. Dynamics in Circulating Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial

    Frontiers in Gastroenterology, Vol. 1

  3. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    The Lancet, Vol. 399, Núm. 10319, pp. 61-116

2020

  1. Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

    Hepatology, Vol. 72, Núm. 1, pp. 198-212

  2. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

2019

  1. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357

2017

  1. Transarterial chemo-embolisation of hepatocellular carcinoma: Impact of liver function and vascular invasion

    British Journal of Cancer, Vol. 116, Núm. 4, pp. 448-454

2016

  1. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: Application of the ALBI grade

    British Journal of Cancer, Vol. 114, Núm. 7, pp. 744-750